Santiago Ramón-García

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Antibiotics (Basel, Switzerland)

British journal of clinical pharmacology

PLoS neglected tropical diseases

Trials

Agencia Aragonesa para la Investigacion y Desarrollo

University of Zaragoza (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Agencia Aragonesa para la Investigacion y Desarrollo Jan 15 2017

Spain

ARAID Investigator :: University of Zaragoza. Faculty of Medicine. Department of Microbiology, Preventive Medicine and Public Health

GlaxoSmithKline España Apr 01 2018 - Mar 31 2020

Spain

Visiting Scientist - Marie Curie Fellow H2020-MSCA-IF-2016-EF-SE :: DDW, Tuberculosis Unit

GlaxoSmithKline España Oct 15 2014 - Jan 14 2017

Spain

Principal Scientist – Marie Curie COFUND fellow :: Diseases of the Developing World (DDW) campus - TB DPU

University of British Columbia Aug 01 2010 - Jan 14 2017

Canada

Research Associate :: Microbiology & Immunology

University of British Columbia Sep 01 2009 - May 31 2014

Canada

Honorary Lecturer :: Faculty of Medicine

University of British Columbia Jan 01 2007 - Jul 31 2010

Canada

Post-Doctoral Research Fellow :: Microbiology & Immunology

University of Padua May 01 2006 - Aug 31 2006

Italy

EMBO Post-Doctoral Research Fellow :: Histology, Microbiology, & Medical Biotechnologies

University of Zaragoza Jan 01 2002 - Apr 06 2006

Spain

PhD student :: Microbiology, Preventive Medicine and Public Health

Education History

University of Zaragoza Sep 15 1999 - Jun 15 2001

Spain

MSC :: Faculty of Science

University of Zaragoza Sep 15 1996 - Jun 15 1999

Spain

BSC :: Faculty of Science

Publications

Diana A Aguilar-Ayala, Fernando Sanz-García, Marie Sylvianne Rabodoarivelo, Budi O Susanto, Rebeca Bailo, Maxime R Eveque-Mourroux, Nicolas Willand, Ulrika S H Simonsson, Santiago Ramón-García, Ainhoa Lucía, null null
Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacin. British journal of clinical pharmacology 90 (7) (2024)
Salvatore D'Agate, Peter Velickovic, Noelia García-Barrios, Santiago Ramón-García, Oscar Della Pasqua
Optimizing β-lactam-containing antibiotic combination therapy for the treatment of Buruli ulcer. British journal of clinical pharmacology (2024)
Diana A Aguilar-Ayala, Fernando Sanz-García, Marie Sylvianne Rabodoarivelo, Budi O Susanto, Rebeca Bailo, Maxime R Eveque-Mourroux, Nicolas Willand, Ulrika S H Simonsson, Santiago Ramón-García, Ainhoa Lucía, null null
Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacin. British journal of clinical pharmacology (2024)
Lara Muñoz-Muñoz, José Antonio Aínsa, Santiago Ramón-García
Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Lara Muñoz-Muñoz, José Antonio Aínsa, Santiago Ramón-García
Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study. Antibiotics (Basel, Switzerland) 12 (2) (2023)
Lara Muñoz-Muñoz, José Antonio Aínsa, Santiago Ramón-García
Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An In Vitro Study. Antibiotics (Basel, Switzerland) 12 (2) (2023)
José Manuel Ezquerra-Aznárez, Giulia Degiacomi, Henrich Gašparovič, Giovanni Stelitano, Jose Camilla Sammartino, Jana Korduláková, Paolo Governa, Fabrizio Manetti, Maria Rosalia Pasca, Laurent Roberto Chiarelli, Santiago Ramón-García
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme. International journal of molecular sciences 23 (2) (2022)
Roch Christian Johnson, Emma Sáez-López, Esaï Sèdjro Anagonou, Godwin Gérard Kpoton, Adjimon Gilbert Ayelo, Ronald Sètondji Gnimavo, Franck Zinsou Mignanwande, Jean-Gabin Houezo, Ghislain Emmanuel Sopoh, Juliet Addo, Lindsay Orford, Georgios Vlasakakis, Nandita Biswas, Felix Calderon, Oscar Della Pasqua, Anna Gine-March, Zaida Herrador, Alfonso Mendoza-Losana, Gabriel Díez, Israel Cruz, Santiago Ramón-García
Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin. Trials 23 (1) (2022)
Lara Muñoz-Muñoz, Carolyn Shoen, Gaye Sweet, Asunción Vitoria, Tim J Bull, Michael Cynamon, Charles J Thompson, Santiago Ramón-García
Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria. Antibiotics (Basel, Switzerland) 10 (4) (2021)
María Pilar Arenaz-Callao, Rubén González Del Río, Ainhoa Lucía Quintana, Charles J Thompson, Alfonso Mendoza-Losana, Santiago Ramón-García
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening. PLoS neglected tropical diseases 13 (1) (2019)

Santiago Ramón-García.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Santiago Ramón-García